PMS-TERIFLUNOMIDE

Pharmascience Inc🇨🇦 Health Canada

Approval Id: 4eade8ff20971f2e
Drug Approval Canada Name: PMS-TERIFLUNOMIDE
Product Name: PMS-TERIFLUNOMIDE
Status: Marketed
Status Date: 2022-05-16
Original Market Date: 2022-05-16
Din: 02500434
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 90:04.20
Atc Original: L04AK02 TERIFLUNOMIDE
Atc Name: l 04 ak 02
Aig Number: 0154970001
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

TERIFLUNOMIDE

14 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

4eade8ff20971f2e

Type

Standard